The EBITDA improved from KEUR 6,330 to KEUR 6,898 (+9.0%), and the Group result improved by 9.1% from KEUR 3,321 to KEUR 3,622 (1st HY 2014). The EBIT was KEUR 3,581 following KEUR 3,250 in the first half year 2013 (+10.2%).

Sales in the Healthcare Software Division increased by 10.8% to KEUR 33,602 (previous year: KEUR 30,340). The Healthcare Service Division increased sales by 4.7% and reached KEUR 4,221 following KEUR 4,032 (1st HY2013).

The second quarter closed with sales of KEUR 19,228 following KEUR 17,768 in Q2 2013 (+8.2 %) and a result before taxes and interest (EBIT) that increased by 9.0% to KEUR 1,769 (Q2 2103: KEUR 1.623). Sales in international business increased by 12.3% from € 13.8 million to € 15.5 million in the first half-year 2014. Business in Germany increased by 8.5% to € 22.4 million. The foreign share in Group sales is mainly at the level of the previous year at 40.8%.

Operative cash flow at the half-year 2014 is substantially higher (+41.3%) with KEUR 5,064 than the 1st half-year level of 2013 of KEUR 3,583. Dividends in the amount of KEUR 1,808 (previous year: KEUR 1,657) have been paid in the half-year 2014. As of 30 June 2014, the balance sheet of the NEXUS AG showed cash on hand and securities worth 24.9 million euros, against which there are no substantial financial liabilities. The equity capital rate was 74%.